NCT00699179 - Observational Study to Evaluate the Efficacy and Safety of NovoMix® 30 in Type 1 and 2 Diabetes | Biotech Hunter

Enrollment

2,308

Participants

Timeline

Start Date

June 30, 2008

Primary Completion Date

September 30, 2009

Study Completion Date

September 30, 2009

Conditions

DiabetesDiabetes Mellitus, Type 1Diabetes Mellitus, Type 2

Interventions

DRUG

biphasic insulin aspart 30

There is no intervention in this trial. The trial is prepared to be non-interventional one. Start dose and frequency to prescribed by the physician as a result of a normal clinical evaluation.

Trial Locations (1)

11 070

Novo Nordisk Investigational Site, Belgrade